Literature DB >> 17626243

Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells.

Tami Rubinek1, Vera Chesnokova, Ido Wolf, Kolja Wawrowsky, George Vlotides, Shlomo Melmed.   

Abstract

The mammalian securin, pituitary tumor-transforming gene (Pttg), regulates sister chromatid separation during mitosis. Mice deficient in Pttg expression exhibit organ-specific hypoplasia of the testis, spleen, pituitary, and postmaturity pancreatic beta-cells, pointing to a possible adult stem cell defect. Bone marrow stem cells (BMSCs) contribute to bone, cartilage, and fat tissue repair and regeneration, and multipotent adult progenitor cells (MAPCs) have broader differentiation ability. Bone marrow cells derived under MAPC conditions are involved in a spectrum of tissue repair. We therefore tested whether Pttg deletion affects stem cell proliferation and differentiation. BMSCs were isolated under MAPC conditions, although unlike MAPCs, wild-type (WT) and Pttg(-/-) BMSCs do not express octamer-binding transcription factor 4 and are stem cell antigen-I positive. WT and Pttg(-/-) cells did not differ in their ability to differentiate into adipogenic, osteogenic, or hepatocyte-like cells or in phenotypic markers. Cells underwent >100 population doublings, with no observed transforming events. Pttg-null BMSCs replicated 27% slower than WT BMSCs, and under hypoxic conditions, this difference widened. Although apoptosis was not enhanced in Pttg(-/-) cells, Pttg(-/-) BMSC senescence-associated beta-galactosidase activity was elevated, consistent with enhanced p21 protein levels. Using gene array assays, DNA repair genes were shown to be upregulated in Pttg(-/-) BMSCs, whereas genes involved in cell cycle progression, including cyclin D(1), were decreased. Separase, the protease regulated by Pttg, has been implicated in DNA damage repair and was downregulated in Pttg(-/-) BMSCs. Separase was constitutively phosphorylated in Pttg(-/-) cells, a modification likely serving as a compensatory mechanism for Pttg deletion. The results indicate that Pttg deletion reduces BMSC proliferation, renders cells more sensitive to hypoxia, and enhances senescent features, thus pointing to a role for Pttg in the maintenance and proliferation of BMSCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626243     DOI: 10.1152/ajpcell.00145.2007

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  7 in total

Review 1.  Pituitary senescence: the evolving role of Pttg.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Mol Cell Endocrinol       Date:  2010-02-12       Impact factor: 4.102

2.  p21(Cip1) restrains pituitary tumor growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kalman Kovacs; Anat Ben-Shlomo; Kolja Wawrowsky; Serguei Bannykh; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

3.  Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Tami Rubinek; Run Yu; Anat Ben-Shlomo; Kalman Kovacs; Kolja Wawrowsky; Shlomo Melmed
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

4.  PTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck Cancer.

Authors:  Martin L Read; Bhavika Modasia; Alice Fletcher; Rebecca J Thompson; Katie Brookes; Peter C Rae; Hannah R Nieto; Vikki L Poole; Sally Roberts; Moray J Campbell; Kristien Boelaert; Andrew S Turnell; Vicki E Smith; Hisham Mehanna; Christopher J McCabe
Journal:  Cancer Res       Date:  2018-08-28       Impact factor: 12.701

5.  Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.

Authors:  M L Read; J C Fong; B Modasia; A Fletcher; W Imruetaicharoenchoke; R J Thompson; H Nieto; J J Reynolds; A Bacon; U Mallick; A Hackshaw; J C Watkinson; K Boelaert; A S Turnell; V E Smith; C J McCabe
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

6.  PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.

Authors:  Jacqueline E Noll; Kate Vandyke; Duncan R Hewett; Krzysztof M Mrozik; Rachel J Bala; Sharon A Williams; Chung H Kok; Andrew Cw Zannettino
Journal:  J Hematol Oncol       Date:  2015-10-06       Impact factor: 17.388

7.  Down-regulation of the oncogene PTTG1 via the KLF6 tumor suppressor during induction of myeloid differentiation.

Authors:  Pei-Yi Chen; Jui-Hung Yen; Ruey-Ho Kao; Ji-Hshiung Chen
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.